Features | Partner Sites | Information | LinkXpress
Sign In
JIB
BioConferenceLive
GLOBETECH PUBLISHING

Marine Microbe Could Help Clear Chronic Sinusitis

By BiotechDaily International staff writers
Posted on 06 Mar 2013
Image: The bacterium Bacillus licheniformis (Photo courtesy of Newcastle University).
Image: The bacterium Bacillus licheniformis (Photo courtesy of Newcastle University).
An enzyme isolated from the marine bacterium Bacillus licheniformis incorporated into a nasal spray could help relieve chronic rhinosinusitis (CRS), according to a new study.

Researchers at Newcastle University (United Kingdom) collected mucous and sinus biopsy samples from 20 different patients, isolating between two and six different species of bacteria from each individual. In the laboratory, 24 different strains were investigated, all of which produced a slimy protective biofilm made up of a mass of bacteria held in a web of extracellular DNA that bind the bacteria to each other. This clumping protects the bacteria from attack by antibiotics, making it very difficult to clear them from the sinuses.

Based on previous studies of the marine bacterium—investigated as a tool for cleaning ship hulls—the researchers found that when the bacteria want to move, they release a deoxyribonuclease enzyme, called NucB, which breaks down the external DNA, resulting in dissolution of the biofilm and release of the bacteria. When NucB was purified and added to 14 other biofilms, the researchers succeeded in quickly dissolving the slimy biofilm, exposing the bacteria and leaving them vulnerable. The study was published on February 19, 2013, in PLOS One.

“In effect, the enzyme breaks down the extracellular DNA, which is acting like a glue to hold the cells to the surface of the sinuses. In the lab, NucB cleared over half of the organisms we tested,” said corresponding author Nicholas Jakubovics, PhD, of Newcastle University.

“For many people, symptoms include a blocked nose, nasal discharge, or congestion, recurrent headaches, loss of the sense of smell and facial pain,” added Mr. Mohamed Reda Elbadawey, a consultant of Otolaryngology Head and Neck Surgery at the Newcastle Hospitals NHS Foundation Trust (United Kingdom). “While steroid nasal sprays and antibiotics can help some people, for the patients I see, they have not been effective and these patients have to undergo the stress of surgery. If we can develop an alternative we could benefit thousands of patients a year.”

Persistent colonization of microbial biofilms is a major factor in the pathogenesis of CRS, with obstructive mucin biofilms detected on the mucosa in the paranasal sinuses, with or without polyps, and in the absence of other symptoms that would indicate fungal rhinosinusitis. The removal of this mucin, which is extremely tenacious, is the cornerstone of surgical treatment of CRS.

Related Links:

Newcastle University
Newcastle Hospitals NHS Foundation Trust



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: In the liver tissue of obese animals with type II diabetes, unhealthy, fat-filled cells are prolific (small white cells, panel A). After chronic treatment through FGF1 injections, the liver cells successfully lose fat and absorb sugar from the bloodstream (small purple cells, panel B) and more closely resemble cells of normal, non-diabetic animals (Photo courtesy of the Salk Institute for Biological Studies).

Fibroblast Growth Factor 1 Treatment Restores Glucose Control in Mouse Diabetes Model

A "vaccine" based on the metabolic regulator fibroblast growth factor 1 (FGF1) removed the insulin resistance that characterizes type II diabetes and restored the body's natural ability to manage its glucose... Read more

Drug Discovery

view channel
Image: Molecular rendering of the crystal structure of parkin (Photo courtesy of Wikimedia Commons).

Cinnamon Feeding Blocks Development of Parkinson's Disease in Mouse Model

A team of neurological researchers has identified a molecular mechanism by which cinnamon acts to protect neurons from damage caused by Parkinson's disease (PD) in a mouse model of the syndrome.... Read more

Lab Technologies

view channel

Precise Ion Irradiation Dosing Method Developed for Cancer Therapy

Scientists are employing nuclear physics principles to provide more effective approaches to radiotherapy treatment for cancer patients. Radiation therapy using heavy ions is best suitable for cancer patients with tumors that are difficult to access, such as in the brain. These particles scarcely damage the penetrated... Read more

Business

view channel

Cancer Immunotherapy Sector Predicted to Surge to USD 9 Billion Across Major Pharma Through 2022

The immunotherapy market will experience substantial growth through 2022, increasing from USD 1.1 billion in 2012 to nearly USD 9 billion in 2022 (corresponding to 23.8% annual growth) in the United Kingdom, United States, France, Germany, Italy, Spain, and Japan, according to recent market research. This notable growth... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.